Cargando…

Questionnaire-based computational screening of adult ADHD

BACKGROUND: ADHD is classically seen as a childhood disease, although it persists in one out of two cases in adults. The diagnosis is based on a long and multidisciplinary process, involving different health professionals, leading to an under-diagnosis of adult ADHD individuals. We therefore present...

Descripción completa

Detalles Bibliográficos
Autores principales: Trognon, Arthur, Richard, Manon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202159/
https://www.ncbi.nlm.nih.gov/pubmed/35706020
http://dx.doi.org/10.1186/s12888-022-04048-1
Descripción
Sumario:BACKGROUND: ADHD is classically seen as a childhood disease, although it persists in one out of two cases in adults. The diagnosis is based on a long and multidisciplinary process, involving different health professionals, leading to an under-diagnosis of adult ADHD individuals. We therefore present a psychometric screening scale for the identification of adult ADHD which could be used both in clinical and experimental settings. METHOD: We designed the scale from the DSM-5 and administered it to n = 110 control individuals and n = 110 ADHD individuals. The number of items was reduced using multiple regression procedures. We then performed factorial analyses and a machine learning assessment of the predictive power of the scale in comparison with other clinical scales measuring common ADHD comorbidities. RESULTS: Internal consistency coefficients were calculated satisfactorily for TRAQ10, with Cronbach’s alpha measured at .9. The 2-factor model tested was confirmed, a high correlation between the items and their belonging factor. Finally, a machine-learning analysis showed that classification algorithms could identify subjects’ group membership with high accuracy, statistically superior to the performances obtained using comorbidity scales. CONCLUSIONS: The scale showed sufficient performance for its use in clinical and experimental settings for hypothesis testing or screening purpose, although its generalizability is limited by the age and gender biases present in the data analyzed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-04048-1.